Marquez-Rodas I, Dutriaux C, Saiag P, de la Cruz Merino L, et al. Erratum: BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203. J Clin Oncol 2025 Jul 24:JCO2501680. doi: 10.1200/JCO-25-01680.
PMID: 40706004